FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1472-1475 April 5, 2007 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Ware, J. H. Related Article by Wang, T. J.

To the Editor: Wang et al. (Dec. 21 issue)¹ suggest that novel biomarkers in aggregate have little influence on the prediction of first cardiovascular events or death. We wonder whether there were sufficient analyses to warrant this conclusion. As described, there were only 68 "major" cardiovascular events in women and 101 in men. In the crucial multimarker analyses, a quarter of these events were eliminated owing to the obligatory inclusion of the urinary albumin-to-creatinine ratio in all the multimarker scores. Would these scores have been more useful if urine biomarkers had been excluded and 100% of the events included?

Second, . . . [Full Text of this Article]

This article has been cited by other articles:

• Shah, T., Casas, J. P, Cooper, J. A, Tzoulaki, I., Sofat, R., McCormack, V., Smeeth, L., Deanfield, J. E, Lowe, G. D, Rumley, A., Fowkes, F G. R, Humphries, S. E, Hingorani, A. D (2008). Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol 0: dyn217v1-dyn217 [Abstract] [Full Text]